BARNWELL INDUSTRIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BARNWELL INDUSTRIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	13.6	13	9.37	12.1	18.3	18.1	28.5	25.3	18.1	13.7
Cost of revenue		3.23	3.65
Gross profit		9.8	5.72
General and administrative	6.7	6.98	6.26	5.52	5.82	7.09	8.04	6.96	5.13	6.94
Operating income	0.54	5.85	3.87	-6.91	0.78	6.35	11.6	5.17	0.3	0.03
Interest expense	0.1	0.01	0.01	0.01	0	0.01	0	0	0	0.01
Interest income	0.05	0.09	0.16	0.06	0.02	0.01	0.02	0.09	0.09	0.05
Pre-tax income	-3.59	1.23	-2.02	-12.6	-4.67	7.54	6.52	-0.86	-3.66	-7.05
Income tax	-0.72	-1.08	-0.6	-0.23	0	0.33	0.35	-0.05	0.21	0.07
Income from continuing operations									-4.11	-7.12
Net income to minority interests	0.75	1.14	0.35	-0	0.08	0.95	0.66	0.15	0.23	-0.01
Net income	-3.62	1.17	-1.77	-12.4	-4.76	6.25	5.51	-0.96	-5.57	-7.1
EBITDA	2.15	7.05	4.98	-3.88	2.93	7.31	14.4	9.63	5.25	3.18
EPS, basic	-0.44	0.14	-0.21	-1.50	-0.57	0.73	0.57	-0.10	-0.56	-0.71
EPS, diluted	-0.44	0.14	-0.21	-1.50	-0.57	0.73	0.57	-0.10	-0.56	-0.71
Shares, basic (weighted)	8.28	8.28	8.28	8.28	8.28	8.59	9.73	9.97	10	10.1
Shares, diluted (weighted)	8.28	8.28	8.28	8.28	8.28	8.59	9.73	9.97	10	10.1
Dividend per share							0.02	0.06	0.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	15.6	16.3	5.97	4.61	4.58	11.3	12.8	2.83	4.29	2.89
Short-term investments	1.19	1.04	0
Receivables				1.32	1.77	2.8	4.04	2.34	1.47	0.91
Other current assets	0.56	0.85	0.95	1.82	1.56	2.47	2.93	3.01	0.87	0.42
Total current assets	21.1	25.1	12.1	8.7	9.49	18	20.1	9.09	8.88	5.23
Property, plant and equipment	6.9	5.37	16.4	8.39	1.47	0.49	13.6	21.8	16.6	9.16
Lease right-of-use assets					0.25	0.3	0.13	0.05	0.04	0.15
Long-term investments	3.55	2.21	1.61	0.98	0.9	0	0			0
Other non-current assets					0				0	0.35
Total assets	31.6	33	31.4	18.3	15.2	24.4	37.2	35.4	30.7	20.8
Accounts payable	1.42	1.19	1.19	1.22	2.1	1.42	1.46	0.88	1.79	2.18
Accrued liabilities	0.45	0.39	0.57	0.21	0.41	1.07	1	0.73	0.53	0.26
Deferred revenue				1.63	1.1	0.46	1.09	0.38	0
Short-term debt	0
Total current liabilities	4.74	4.8	3.63	4.77	6.36	5.9	8.93	6.6	7.81	4.73
Long-term debt				0	0.06	0.05	0.04	0
Lease liabilities					0.14	0.18	0.12	0.05	0.01	0.09
Total liabilities	17.8	14.8	15.1	17	17.1	14.9	18.1	16.7	17.6	13.8
Total debt	0			0	0.06	0.05	0.04	0
Paid-in capital	1.35	1.35	1.35	1.35	1.35	4.59	7.35	7.69	7.69	8.04
Retained earnings	13.9	15	13.3	0.86	-3.9	2.36	7.72	6.16	0.6	-6.51
Treasury stock	-2.29	-2.29	-2.29	-2.29	-2.29	-2.29	-2.29	-2.29	-2.29	-2.29
Other comprehensive income	-3.92	-1.06	-0.51	-2.92	-1.44	0.03	1.29	2.1	1.94	2.64
Shareholders' equity	13.2	17.3	16	1.23	-2.05	9.5	19.1	18.7	13	7.01
Minority interests	0.53	0.93	0.21	0.1	0.09	0.01	0.02	0.01	0.02	0.01
Total equity	13.7	18.2	16.2	1.33	-1.95	9.51	19.2	18.8	13.1	7.02
Total liabilities and equity	31.6	33	31.4	18.3	15.2	24.4	37.2	35.4	30.7	20.8

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-2.86	2.31	-1.42	-12.4	-4.68	7.2	6.17	-0.81	-5.33	-7.11
Depreciation and amortization	1.61	1.2	1.11	3.02	2.15	0.96	2.78	4.46	4.95	3.15
Stock-based compensation	-0.02	0.02	-0.06	-0.04	0	0.64	0.66	0.26	0.21	0.37
Deferred income tax	-0.07	-0.27	0.38	-0.14	0.03	0.17	-0.17	-0.13	0.04	-0.08
Change in receivables	0.93	-0.12	-0.57	-0.26	-0.6	-0.81	-1.76	1.1	0.61	0.19
Change in payables	-1.46	-0.28	0.12	-0.2	0.92	-0.75	0.11	-0.6	1.02	0.46
Cash from operations	1.77	-2.12	-5.09	-2.13	0.75	0.83	7.29	1.94	4.71	-1.77
Capital expenditures	-1	-0.81	-0.75	-1.31	-3.51	-3.09	-13.8	-12.5	-4.23	-0.25
Purchases of investments	0	-7.14	-3.96	0
Sales and maturities of investments	0	2.73	7.63	0.74
Cash from investing	9.38	2.91	-3.88	0.91	-0.83	3.69	-7.11	-11.2	-2.83	-0.35
Debt issued				0	0.15	0.05	0
Debt repaid	-3.44	0					0	-0.03	0
Stock issued					0	3.18	2.36	0
Dividends paid						0	-0.15	-0.6	0
Cash from financing	-4.25	-0.37	-1.07	-0.11	0.06	2.19	1.56	-0.79	-0.23	-0.17
Exchange rate effect			-0.27	-0.01	-0.01	-0.01	-0.21	0.05	0.02	-0.11
Net change in cash			-10.3	-1.35	-0.03	6.7	1.53	-9.97	1.68
Free cash flow	0.77	-2.93	-5.84	-3.44	-2.76	-2.26	-6.51	-10.6	0.48	-2.03
Interest paid	0.09	0.01	0.01
Income taxes paid	-0.22	-0.09	-0.02	-2.3	-0.17	-0.3	-0.1	0.1	0.07	0.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.94 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	2.2%	Operating income / revenue.
EBITDA margin	22.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-46.2%	Pre-tax income / revenue.
Net margin	-46.7%	Net income / revenue.
Operating cash flow margin	-31.8%	Cash from operations / revenue.
Return on equity (ROE)	-61.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-25.3%	Net income / average total assets.
Return on invested capital (ROIC)	4.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	3.1%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	20.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-24.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-21.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-5.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-90.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-86.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-47.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-39.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-39.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	1.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-137.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-520.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-46.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-28.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	-32.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-17.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.90x	Current assets / current liabilities.
Quick ratio	1.60x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.31x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	58.4%	Total liabilities / total assets.
Working capital	$3.1M	Current assets - current liabilities.
Tangible book value	$8.9M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.54x	Revenue / average total assets.
Fixed asset turnover	1.48x	Revenue / average property, plant and equipment.
Receivables turnover	11.6x	Revenue / average receivables.
Days sales outstanding	32 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.38	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$0.81	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.26	Cash from operations / diluted weighted shares.
Book value per share	$0.62	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.62	Tangible book value / shares outstanding.
Cash per share	$0.31	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$13.6M	Share price x shares outstanding.
Enterprise value	$9.1M	Market cap + total debt - cash - short-term investments.
P/S	1.16x	Market cap / revenue.
P/B	1.53x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.53x	Market cap / tangible book value, when positive.
EV/Sales	0.78x	Enterprise value / revenue.
EV/EBIT	35.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	3.51x	Enterprise value / EBITDA, when both are positive.
Earnings yield	-40.1%	Net income / market cap (the inverse of P/E).

What was BARNWELL INDUSTRIES INC's revenue in fiscal 2025?

BARNWELL INDUSTRIES INC reported revenue of $13.7M for fiscal 2025, 24.2% lower than the year before.

Was BARNWELL INDUSTRIES INC profitable in fiscal 2025?

No. It reported a net loss of $7.1M.

How much free cash flow did BARNWELL INDUSTRIES INC generate in fiscal 2025?

Cash from operations of $1.8M minus capital expenditures of $254.0K left free cash flow of -$2.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BARNWELL INDUSTRIES INC